(tiny URL) Rhogam - Thimerosal (Mercury) Exposure during Pregnancy Linked to Autistic Disorders

[Guest guest]

http://www.nccn.net/~wwithin/A Prospective Study of Rho Immune Globulin as

a Risk Factor for Autism1.pdf OR

http://tinyurl.com/2huukp

Also see my Rhogam pages

http://www.nccn.net/~wwithin/rhogam.htm

Thimerosal (Mercury) Exposure during Pregnancy Linked to Autistic Disorders

Press Release Contact:

For Immediate Release CoMeD Director [Rev. Sykes (Richmond,

VA) 804-364-8426]

May 18, 2007 CoMeD Sci. Advisor [Dr. King

(Lake Hiawatha, NJ) 973-997-1321]

WASHINGTON, DC – In the May 2007 issue of the Journal of Maternal-Fetal and

Neonatal Medicine

(http://www.informaworld.com/smpp/content~content=a778637558~db=all~order=pa

ge), the official journal of the European Association of Perinatal

Medicine, the Federation of Asia and Oceania and Perinatal Societies, and

the International Society of Perinatal Obstetricians, a new study, “A

Prospective Study of Thimerosal-Containing Rho(D)-Immune Globulin

Administration as a Risk Factor for Autistic Disorders,” was published by

Dr. Mark R. Geier (President, the Genetic Centers of America) and A.

Geier (Vice-President, the Institute of Chronic Illnesses). This new study

shows that administration of Thimerosal-preserved Rho(D)-immune g lobulin

preparations during pregnancy significantly increases the risk for

offspring developing autistic disorders. This finding is consistent with

previously published research by Dr. Amy Holmes, Mark Blaxill, and Dr. Boyd

Haley in the International Journal of Toxicology (2003), and refutes the

recent study funded by & (a maker of Rho(D)-immune

globulins) that failed to find an association between Thimerosal-preserved

Rho(D)-immune globulins and autistic disorders.

Since the late 1980s, Rho(D)-immune globulin preparations have been

routinely administered to Rh-negative women in the US during pregnancy at

28 weeks gestation, a prenatal period corresponding to damage occurring in

the fetal brain, that has been associated with autistic disorders.

Unfortunately, until 2001, some formulations of Rho(D)-immune globulins

manufactured for the US market contained Thimerosal, a mercury-containing

compound (49.6% mercury by weight). As a result, administration of

Thimerosal-preserved Rho(D)-immune globulins exposed Rh-negative pregnant

women to bolus doses of mercury ranging from 10.5 t o greater than 30

micrograms mercury per administration at critical prenatal developmental

periods. In some cases, Rh-negative women received several Rho(D)-immune

globulins during their pregnancy. In addition, if the fetus was

Rh-positive, the mother was administered another Rho(D)-immune globulin

after birth. When that infant was breastfed, then, that infant would

receive another significant mercury exposure.

In this new study, the researchers examined a total of 53 non-Jewish

Caucasian patients with a diagnosis of an autistic spectrum disorder (ASD),

born from 1987 through 2001, who prospectively presented to the Genetic

Centers of America for outpatient genetic/developmental evaluations from

June 1, 2005 through March 31, 2006. Imaging and laboratory testing were

conducted to rule-out other causal factors for their ASDs. As race-matched

controls, the frequency of Rh-negativity was determined from 926 non-Jewish

Caucasian pregnant women who presented for outpatient prenatal genetics

care to the Genetic Centers of America between 1980 and 1989. Children with

a diagnosis of an ASD were more than twice as likely to have an Rh-negative

mo ther than the controls. Each ASD patient with an Rh-negative mother was

administered a Thimerosal-preserved Rho(D)-immune globulin during her

pregnancy. These researchers concluded that their results provide insights

into the causal role prenatal mercury exposure may play in some children

diagnosed with autistic disorders.

Note: For those who wishing to confirm, whether or not, their child is

mercury poisoned, they may want to have a urine porphyrin profile analysis

(UPAA) test done. For more information, visit the Coalition for

Mercury-free Drugs (CoMeD)’s web site:

http://www.Mercury-freeDrugs.org

--------------------------------------------------------

Sheri Nakken, R.N., MA, Hahnemannian Homeopath

Vaccination Information & Choice Network, Nevada City CA & Wales UK

Vaccines - http://www.nccn.net/~wwithin/vaccine.htm